The challenger Beacon produces first generic version of Gilead’s newly launched Epclusa — a drug used to treat all types of Hepatitis C.

The drug called Epclusa which is developed to treat all genotypes of the Hepatitis C virus by Gilead Sciences in its latest breakthrough tr...